JP2014519526A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2014519526A5 JP2014519526A5 JP2014516041A JP2014516041A JP2014519526A5 JP 2014519526 A5 JP2014519526 A5 JP 2014519526A5 JP 2014516041 A JP2014516041 A JP 2014516041A JP 2014516041 A JP2014516041 A JP 2014516041A JP 2014519526 A5 JP2014519526 A5 JP 2014519526A5
- Authority
- JP
- Japan
- Prior art keywords
- polypeptide
- residue
- seq
- residues
- methionine
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201161497270P | 2011-06-15 | 2011-06-15 | |
| US61/497,270 | 2011-06-15 | ||
| PCT/US2012/042699 WO2012174397A2 (en) | 2011-06-15 | 2012-06-15 | Anti-inflammatory pharmaceutical products |
| US13/524,381 | 2012-06-15 | ||
| US13/524,381 US9102753B2 (en) | 2011-06-15 | 2012-06-15 | Anti-inflammatory pharmaceutical products |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2014519526A JP2014519526A (ja) | 2014-08-14 |
| JP2014519526A5 true JP2014519526A5 (https=) | 2015-07-30 |
| JP6069663B2 JP6069663B2 (ja) | 2017-02-01 |
Family
ID=47357770
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2014516041A Active JP6069663B2 (ja) | 2011-06-15 | 2012-06-15 | 抗炎症医薬製品 |
Country Status (12)
| Country | Link |
|---|---|
| US (2) | US9102753B2 (https=) |
| EP (2) | EP3533457B1 (https=) |
| JP (1) | JP6069663B2 (https=) |
| CN (1) | CN103764669B (https=) |
| AU (1) | AU2012271453B2 (https=) |
| BR (1) | BR112013032088B1 (https=) |
| CA (1) | CA2839298C (https=) |
| DK (1) | DK2720707T3 (https=) |
| ES (1) | ES2712805T3 (https=) |
| HU (1) | HUE042929T2 (https=) |
| PL (1) | PL2720707T3 (https=) |
| WO (1) | WO2012174397A2 (https=) |
Families Citing this family (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US8377863B2 (en) | 2007-05-29 | 2013-02-19 | Unigene Laboratories Inc. | Peptide pharmaceutical for oral delivery |
| US9102753B2 (en) * | 2011-06-15 | 2015-08-11 | Ugp Therapeutics, Inc. | Anti-inflammatory pharmaceutical products |
| US9457086B2 (en) | 2013-03-05 | 2016-10-04 | Enteris Biopharma, Inc. | Pharmaceuticals for oral delivery |
| DK3244878T3 (da) | 2015-01-12 | 2022-10-17 | Enteris Biopharma Inc | Faste orale sammensætningsformer |
| PL4200319T3 (pl) | 2020-08-21 | 2025-08-18 | Resother Pharma A/S | Preparaty peptydu n-końcowego aneksyny a1 i sposoby |
| CN118891273A (zh) | 2022-02-23 | 2024-11-01 | 雷索特制药股份有限公司 | 膜联蛋白a1衍生的多肽类似物 |
| US20250345392A1 (en) | 2022-06-30 | 2025-11-13 | Resother Pharma A/S | Annexin a1 liquid pharmaceutical composition |
| AU2024234229A1 (en) | 2023-03-13 | 2025-09-25 | Resother Pharma A/S | Annexin a1 administration regime |
| EP4680262A1 (en) | 2023-03-13 | 2026-01-21 | Resother Pharma A/S | Annexin a1 delayed dosing |
Family Cites Families (16)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6319685B1 (en) | 1984-09-27 | 2001-11-20 | Unigene Laboratories, Inc. | Alpha-amidating enzyme compositions and processes for their production and use |
| US4708934A (en) | 1984-09-27 | 1987-11-24 | Unigene Laboratories, Inc. | α-amidation enzyme |
| US5789234A (en) | 1987-08-14 | 1998-08-04 | Unigene Laboratories, Inc. | Expression systems for amidating enzyme |
| WO1998046722A1 (en) | 1997-04-16 | 1998-10-22 | Unigene Laboratories Inc. | Direct expression of peptides into culture media |
| US6086018A (en) | 1997-12-09 | 2000-07-11 | Mcdonnell Douglas Corporation | Interlocking assembly system for an aircraft cabin |
| US20090163578A1 (en) * | 2004-10-01 | 2009-06-25 | University Of Medicine And Dentistry Of New Jersey | Novel modification of immunomodulatory protein |
| US7445911B2 (en) | 2004-11-24 | 2008-11-04 | Unigene Laboratories Inc. | Enzymatic reactions in the presence of keto acids |
| AU2006261909B2 (en) | 2005-06-24 | 2011-08-11 | Enteris Biopharma, Inc. | Cell lines for expressing enzyme useful in the preparation of amidated products |
| CN101287503A (zh) * | 2005-08-03 | 2008-10-15 | Rq生物科技有限公司 | 用于诊断IgA和IgM介导的肾脏疾病的方法和组合物 |
| CN101273059B (zh) | 2005-08-26 | 2014-02-19 | 艾伯维有限公司 | 治疗活性的α-MSH类似物 |
| US8691764B2 (en) * | 2007-03-28 | 2014-04-08 | The Research Foundation For The State University Of New York | Inhibitors of NF-κB activity |
| US8377863B2 (en) | 2007-05-29 | 2013-02-19 | Unigene Laboratories Inc. | Peptide pharmaceutical for oral delivery |
| GB0724953D0 (en) | 2007-12-20 | 2008-01-30 | Lytix Biopharma As | Methods of peptide modification |
| EP2349321B1 (en) | 2008-10-17 | 2020-04-22 | London Health Sciences Centre Research Inc. | Annexin and its use to treat inflammatory disorders |
| US8940697B2 (en) * | 2009-10-16 | 2015-01-27 | Duke University | Compositions and methods for the treatment of myocardial ischemia/reperfusion injury with Annexin A1 short peptide |
| US9102753B2 (en) * | 2011-06-15 | 2015-08-11 | Ugp Therapeutics, Inc. | Anti-inflammatory pharmaceutical products |
-
2012
- 2012-06-15 US US13/524,381 patent/US9102753B2/en active Active
- 2012-06-15 AU AU2012271453A patent/AU2012271453B2/en active Active
- 2012-06-15 EP EP18212844.7A patent/EP3533457B1/en active Active
- 2012-06-15 CA CA2839298A patent/CA2839298C/en active Active
- 2012-06-15 JP JP2014516041A patent/JP6069663B2/ja active Active
- 2012-06-15 BR BR112013032088-5A patent/BR112013032088B1/pt active IP Right Grant
- 2012-06-15 EP EP12799815.1A patent/EP2720707B1/en active Active
- 2012-06-15 WO PCT/US2012/042699 patent/WO2012174397A2/en not_active Ceased
- 2012-06-15 PL PL12799815T patent/PL2720707T3/pl unknown
- 2012-06-15 DK DK12799815.1T patent/DK2720707T3/en active
- 2012-06-15 ES ES12799815T patent/ES2712805T3/es active Active
- 2012-06-15 HU HUE12799815A patent/HUE042929T2/hu unknown
- 2012-06-15 CN CN201280028984.3A patent/CN103764669B/zh active Active
-
2015
- 2015-07-20 US US14/803,426 patent/US10072055B2/en active Active
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2014519526A5 (https=) | ||
| FI3256579T3 (fi) | Kysteiiniproteaasi | |
| WO2012174397A3 (en) | Anti-inflammatory pharmaceutical products | |
| EP3363458A3 (en) | A peptide | |
| JP2014224126A5 (https=) | ||
| MX385794B (es) | Péptidos inhibidores obtenidos del receptor desencadenante expresado en células mieloides de tipo 1 (trem-1) y transcrito similar a trem 1 (tlt-1) y usos de los mismos. | |
| IN2014KN01713A (https=) | ||
| IN2014KN01716A (https=) | ||
| IN2014KN01714A (https=) | ||
| PL393578A1 (pl) | Przeciwnowotworowe białko fuzyjne | |
| JP2012115277A5 (https=) | ||
| WO2011036443A9 (en) | S1 protease c- terminal polypeptides and uses thereof for treating inflammation or coagulation disorders | |
| MX2014008028A (es) | Proteina de fusion anticancerigena. | |
| MX2015011243A (es) | Peptidos para su uso en el tratamiento topico de enfermedades neurodegenerativas retinianas, en particular en fases de tempranas de retinopatia diabetica y otras enfermedades retinianas en las cuales la neurodegeneracion desempeña una funcion esencial. | |
| NZ602845A (en) | Inhibiting peptides derived from trem-like transcript 1 (tlt-1) and uses thereof | |
| JP2019533722A5 (https=) | ||
| NZ736652A (en) | Short synthetic peptide for treating diseases and/or conditions related to angiogenesis | |
| MX2008009493A (es) | Peptido novedoso y uso del mismo. | |
| JP2016536357A5 (https=) | ||
| JP2017505772A5 (https=) | ||
| JP2016515123A5 (https=) | ||
| NZ703514A (en) | Fviii peptides for immune tolerance induction and immunodiagnostics | |
| EA201590601A1 (ru) | Применение pedf-производных полипептидов для лечения остеоартрита | |
| NZ590469A (en) | Treatment of rheumatoid arthritis with human beta defensins (1-4) | |
| PL394618A1 (pl) | Przeciwnowotworowe bialko fuzyjne |